Baker Bros. Advisors’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $1.13M | Hold |
|
|||||
|
2022
Q4 | $752K | Hold |
|
|||||
|
2022
Q3 | $1.36M | Hold |
|
|||||
|
2022
Q2 | $2.18M | Hold |
|
|||||
|
2022
Q1 | $2.08M | Hold |
|
|||||
|
2021
Q4 | $3.51M | Buy |
|
|||||
|
2021
Q3 | $1.5M | Hold |
|
|||||
|
2021
Q2 | $2.9M | Hold |
|
|||||
|
2021
Q1 | $3.9M | Buy |
|
|||||
|
2020
Q4 | $3.43M | Sell |
|
|||||
|
2020
Q3 | $2.49M | Buy |
|